Transplantation of stromal cells transduced with the human IL3 gene to stimulate hematopoiesis in human fetal bone grafts in non-obese, diabetic-severe combined immunodeficiency mice

Leukemia

Volumn 12, Issue 7, 1998, Pages 1128-1135

  Brouard, N ^a,b   Chapel, A ^a   Neildez Nguyen, T M A ^a   Granotier, C ^a   Khazaal, I ^b   Peault B ^b   Thierry, D ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b CNRS   (France)

Author keywords

Bone marrow stromal cells; Gene transfer; Interleukin 3; NOD SCID mouse

Indexed keywords

INTERLEUKIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE GRAFT; BONE MARROW; CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROPORATION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIESIS; LIVER; LUNG; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; STROMA CELL;

EID: 0031854820     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401081     Document Type: Article

References (12)

1. Dührsen U, Hossfeld DK. Stromal abnormalities in neoplastic bone marrow diseases. Ann Hematol 1996; 73: 53-70.
2. Schwartz CN, Kessler SW, Rothwell SW, Burrell LM, Reid TJ, Meltzer MS, Wright FC. Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. Exp Hematol 1994; 22: 1288-1296.
3. Bahner I, Kearns K, Coutinho S, Leonard EH, Kohn DB. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 1997; 90: 1787-1798.
4. Greenberger JS. Methods for the use of stromal cells for therapeutic gene therapy. In: Robbins PD (ed). Methods in Molecular Medicine, Gene Therapy Protocols. Humana Press: Totowa, NJ, 1997, pp 375-390.
5. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Péault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804-2808.
6. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992; 79: 1704-1711.
7. Kyoizumi S, Murray LJ, Namikawa R. Preclinical analysis of cytokine therapy in the SCID-hu mouse. Blood 1993; 81: 1479-1488.
8. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiang LX, Kato I, Williams DA, Dick JE. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nature Med 1996; 2: 1329-1337.
9. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and non-obese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 1996; 88: 3731-3740.
10. Itoh K, Tezuka H, Sakoda H, Konnp M, Nagata K, Uchiyama T, Uchino H, Mori KJ. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol 1989; 17: 145-153.
11. - progenitor cells in long-term cultures and semisolid assays. Blood 1993; 81: 2916-2924.
12. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313: 812-815.